Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0300
-0.0100 (-25.00%)
May 16, 2025, 4:00 PM EDT
Accelerate Diagnostics Revenue
In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.
Revenue
11.70M
Revenue Growth
-2.99%
P/S Ratio
0.06
Revenue / Employee
109.33K
Employees
107
Market Cap
755.60K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.70M | -361.00K | -2.99% |
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 30.44B |
Federal Home Loan Mortgage | 23.43B |
Music Licensing | 128.87M |
Jingbo Technology | 1.96M |
Alpine Auto Brokers | 129.78K |
First National of Nebraska | 1.89B |
Mechanics Bank | 381.61M |
Endo Inc. | 1.73B |
Accelerate Diagnostics News
- 9 days ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 2 months ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 2 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 4 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 7 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 8 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire